Blocking CCL24 was shown to reduce liver damage in various experimental animal models of MASH, including the methionine-choline-deficient (MCD) diet-induced and streptozotocin-high-fat-diet (STAM)-induced MASH models, and the thioacetamide (TAA)-induced liver fibrosis model [143]. Here, CCL24 is linked to metabolic dysfunction-associated steatohepatitis.